Tris Pharma, Inc. (United States) holds 8 active US FDA Type II Drug Master Files. 24 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Tris Pharma, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/tris-pharma-inc

Overview

Tris Pharma, Inc. is a leading pharmaceutical company specializing in the development and commercialization of innovative drug delivery technologies. The company focuses on improving patient outcomes by developing novel drug formulations and therapies.

Therapeutic areas

API / Drug Master Files

Tris Pharma, Inc. holds 8 active (8 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • NEXICLON XR (CLONIDINE) EXTENDED-RELEASE TABLETSActive2021-02-19
  • KARBINAL ER (CARBINOXAMINE MALEATE) EXTENDED-RELEASE ORAL SUSPENSION EQ. TO 4 MG CARBINOXAMINE MALEATE PER 5 MLActive2019-11-04
  • OXYBATE FOR EXTENDED-RELEASE ORAL SUSPENSION (OXYBATE FOR ER OS)Active2018-09-11
  • COD-CPM-PSE ER ORAL SUSPENSIONActive2015-11-03
  • HCD-CPM-PSEUD ER OS (HYDROCODONE POLISTIREX, CHLORPHENIRAMINE POLISTIREX AND PSEUDOEPHEDRINE POLISTIREX ER ORAL SUSPENSION)Active2015-07-17
  • COD-CPM ER ORAL SUSPENSIONActive2013-07-26
  • METHYLPHENIDATE ERCT (METHYLPHENIDATE HCI ER CHEWABLE TABLETS)Active2012-04-18
  • METHYLPHENIDATE ERL (METHYLPHENIDATE ER POWDER FOR ORAL SUSPENSION)Active2010-07-20

FDA compliance signals

24 FDA enforcement records linked to this company.

  • 4832025-11-21

    Investigations of discrepancies, failures

  • 4832024-03-08

    Failure to develop written procedures

  • 4832024-03-08

    Failure to submit scientific article

  • 4832021-06-08

    Failure to meet specifications

  • 4832021-06-08

    Protective Apparel Not Worn

  • 4832021-06-08

    Cleaning / Sanitizing / Maintenance

  • 4832021-06-08

    Buildings not maintained in good state of repair

  • 4832021-06-08

    Extent of discrepancy, failure investigations

  • 4832021-06-08

    Procedures not in writing, fully followed

  • 4832021-06-08

    Computer control of master formula records

  • recall — Class II2019-07-31

    Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.

  • recall — Class II2019-02-20

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

  • recall — Class II2019-02-20

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

  • recall — Class II2019-02-20

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.

  • 4832019-01-23

    Written program not followed

  • 4832019-01-23

    Investigations of discrepancies, failures

  • recall — Class II2018-12-26

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

  • recall — Class II2018-12-26

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

  • recall — Class II2018-12-26

    Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

  • 4832018-04-16

    Late submission of 15-day report

  • 4832018-04-16

    Failure to develop written procedures

  • warning_letter2018-03-28

    FDA Warning Letter (drug product)

  • recall — Class II2017-09-06

    Defective container: Oral solution leaking from container.

  • 4832015-08-12

    Late submission of quarterly safety reports

For suppliers

Is this Tris Pharma, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.